10.03.2013

The shares of drug producers Antibiotice Iasi (ATB.RO) and Biofarm Bucuresti (BIO.RO) generated over 50% profits in the past year, including the dividends paid to shareholders, which makes them some more

09.23.2013

Romania’s state-run drugmaker Antibiotice Iasi can grow to become a player in the region, but with support from an investor and improved legislation, the company’s general manager Ioan Nani said more

08.14.2013

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) Wednesday said its net profit fell 37.3% to 16.1 million lei (EUR3.63 million) in the first half of 2013, on lower sales. more

08.07.2013

Romanian state-run drug maker Antibiotice Iasi (ATB.RO) is looking to open offices in ten countries, including Poland, Czech Republic, Slovakia, Ukraine, and Serbia, to increase its visibility and more

08.06.2013

Sales of Romanian state-run drug maker Antibiotice Iasi (ATB.RO) declined 4% in the first half of the year, to RON141.8 million (EUR32.3 million), and its net profit dropped 37%, to RON16.1 million more

07.02.2013

Romanian state-run drug maker Antibiotice Iasi (ATB.RO) has borrowed 60 million lei (EUR13.5 million) from lender EximBank to finance its activity. more

06.27.2013

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) will increase its share capital by 10.3 million lei (EUR2.3 million) to RON67.1 million, according to a shareholder decision Thursday. more

05.15.2013

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) Wednesday said its net profit fell 57.6% to 5.5 million lei (EUR6 million) in the first three months of 2013, as domestic sales were hit by weak more

04.04.2013

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) estimates its net profit will rise 6% to 29 million lei (EUR6.5 million) in 2013, according to the company’s revenue and expenditure budget for more

02.20.2013

Romanian state-owned drugmaker Antibiotice Iasi SA (ATB.RO) Wednesday said its preliminary net profit rose 33% in 2012 to 27.4 million lei (EUR6.1 million). more

01.29.2013

Romanian state-run drug producer Antibiotice Iasi (ATB.RO) forecasts 17% higher exports in 2013 from $20 million in 2012, fueled by expanded partnerships on the US market as well as on other more

12.26.2012

Romanian state-run drug producer Antibiotice Iasi (ATB.RO) is aiming for EUR124 million sales by 2016, an increase of 77% from the almost EUR70 million expected this year. more

12.20.2012

Romanian state-owned drug producer Antibiotice Iasi (ATB.RO) will hit its sales and profit targets this year, says general manager Ioan Nani, while 2013’s sales should follow the trend of the more

11.15.2012

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) Thursday said its net profit rose 7% to 26.6 million lei (EUR6 million) in the first nine months, fueled by a similar increase in sales. more

10.17.2012

The Romanian Government Wednesday authorized the purchasing of 27 vehicles for Romanian state-owned drugmaker Antibiotice Iasi SA (ATB.RO), which is aimed to increase the number of sales agents as more

08.09.2012

Romanian state-owned drugmaker Antibiotice Iasi SA (ATB.RO) Thursday said its net profit rose 11.2% on the year to 25.75 million lei (EUR5.8 million) in the first half, helped by higher sales. more

06.21.2012

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) took two credit lines of EUR9.5 million and 8 million lei (EUR1.8 million) to finance its working capital, the company said in a statement sent more

05.15.2012

Romanian drugmaker Antibiotice Iasi (ATB.RO) Tuesday reported a net profit of 12.97 million lei (EUR2.9 million) for the first quarter, down 2.2% on the year, as higher financial costs hurt the bottom more

04.27.2012

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) Friday rejected a proposal to increase its share capital by 17.2 million lei (EUR3.93 million), authorizing instead a dividend payout from the more

03.23.2012

The managing board of Romanian state-owned medicine maker Antibiotice Iasi (ATB.RO) increased to 17.2 million lei (EUR3.9 million) the sum proposed to stockholders as share capital hike, according to more

03.14.2012

Romanian state-owned medicine maker Antibiotice Iasi (ATB.RO) expects pretax profit to reach 29.9 million lei (EUR6.86 million) this year, up 13% from RON26.4 million in the previous year, according more

02.20.2012

Biofarm (BIO.RO) was the most profitable pharmaceuticals company on the Bucharest stock exchange last year. Despite a two-percentage point drop in net profit margin to 15.5%, the drugmaker surpassed more

02.13.2012

Romanian state-run drugmaker Antibiotice Iasi (ATB.RO) Monday said its net profit rose 60% to 20 million lei (EUR4.7 million) in 2011, fueled by a 15% increase in sales. more

11.14.2011

Romanian state-owned medicine maker Antibiotice Iasi (ATB.RO) on Monday reported a 17.7% year-on-year increase in its nine-month net profit, to 24.85 million lei (EUR5.9 million), form RON21.11 more

10.24.2011

State-owned drugmaker Antibiotice Iasi SA (ATB.RO) estimates its sales on the US market will grow 36% on the year to $4.5 million in 2012, after it has received official authorization to trade a new more